EB vs VRTX · rev $291.8M vs P/E 30, rev $12.00B
Eventbrite Inc Class A (EB) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Eventbrite Inc Class A (EB) is a internet content & information company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported EB revenue for 2025-12-31 was $291.8M. Net income was -$10.5M. Revenue was down 10.2% from 2024-12-31 to 2025-12-31. EB currently screens at market cap $453.0M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
EB currently screens at market cap $453.0M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the EB and VRTX stock pages for the full models.
Not investment advice.